NASDAQ:NAMS | EBITDA Margin | NewAmsterdam Pharma Co N.V.

Complete source-backed ebitda margin history.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-1919.67%
2025-12-31-206003.13%
2025-03-31-2312.73%
2024-12-31-338.07%
2024-03-31-3959.10%
2023-12-31-6358.78%
2023-03-31-461.75%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-1001.92%
2024-12-31-386.66%
2023-12-31-1298.21%
2022-12-31-3.45%